Testing Tumor Tissue and Blood to Help Select Personalized Treatments for Patients With Suspected Lung Cancers

ClinicalTrials.gov ID: NCT04712877

Public ClinicalTrials.gov record NCT04712877. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Jul 23, 2026, 10:50 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

LEADER Neoadjuvant Screening Trial: LCMC4 Evaluation of Actionable Drivers in Early Stage Lung Cancers

Study identification

NCT ID: NCT04712877
Recruitment status: Recruiting
Study type: Observational
Phase: Not listed
Lead sponsor: Lung Cancer Mutation Consortium; Network
Enrollment: 1,000 participants

Conditions and interventions

Conditions

NSCLC

Interventions

ctDNA, tumor NGS Diagnostic Test

Diagnostic Test

Eligibility (public fields only)

Age range: Not listed
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Jun 14, 2022
Primary completion: Jun 14, 2025
Completion: Jun 14, 2026
Last update posted: Jul 16, 2024

2022 – 2026

United States locations

U.S. sites: 21
U.S. states: 13
U.S. cities: 16

Facility	City	State	ZIP	Site status
University of California, Davis	Davis	California	95616	Recruiting
USC Norris Comprehensive Cancer Center	Los Angeles	California	90033	Recruiting
UCLA	Los Angeles	California	90095	Recruiting
St. Joseph's Hospital Orange	Orange	California	92868	Recruiting
Moffitt Cancer Center	Tampa	Florida	33612	Recruiting
Northwestern University	Chicago	Illinois	60611	Recruiting
Massachusetts General Hospital	Boston	Massachusetts	02114	Recruiting
Brigham and Women's Hospital	Boston	Massachusetts	02115	Recruiting
Boston Medical Center	Boston	Massachusetts	02118	Recruiting
Dana-Farber Cancer Institute	Boston	Massachusetts	02215	Recruiting
University of Michigan	Ann Arbor	Michigan	48109	Recruiting
University of Missouri	Columbia	Missouri	65212	Recruiting
Washington University	St Louis	Missouri	63110	Recruiting
Dartmouth-Hitchcock	Lebanon	New Hampshire	03756	Recruiting
NYU	New York	New York	10016	Recruiting
Columbia University	New York	New York	10032	Recruiting
Ohio State University	Columbus	Ohio	43210	Recruiting
Medical University of South Carolina	Charleston	South Carolina	29425	Recruiting
Baylor College of Medicine	Houston	Texas	77030	Recruiting
Virginia Cancer Specialists, PC	Fairfax	Virginia	22031	Recruiting
University of Washington	Seattle	Washington	98019	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT04712877, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Jul 16, 2024 · Synced Jul 23, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04712877 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →